Filing Flows

Filing Flows › Tenon Medical (TNON) › Q4 2025

Tenon Medical (TNON) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Mar 27, 2026

Tenon Medical (TNON) reported revenue of $1.5M for the fourth quarter 2025 (Q4 2025), +92% from a year earlier and +26% from the quarter before. Operating margin was -193.5%, net loss $2.8M (191.2% of revenue).

Revenue$1.5M
Year over year+92%
Quarter over quarter+26%
Operating margin-193.5%
Net earnings−$2.8M

Tenon Medical, Q4 2025: revenue $1.5M (+92% year over year), operating margin -193.5%, net loss $2.8M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$1.5M+26%+92%
Operating profit−$2.9M——
Net earnings−$2.8M——
Operating cash flow−$2.2M——

What changed

Revenue was $1.5M in Q4 2025, up 92% year over year and up 26% from the previous quarter.

Gross margin was 68.7%, up 22.8 points from Q4 2024. Operating costs exceeded revenue by $2.9M, an operating margin of -193.5%. Operating expenses grew 10% against revenue growth of 92%. The fastest-growing cost line was Sales & marketing (+61%). The quarter ended with a net loss of $2.8M, narrower than the previous quarter's $3.3M loss.

Operating cash flow was −$2.2M. Non-cash charges added back $95K of depreciation and amortization and $344K of share-based compensation. Working capital and other items added $169K. Capital expenditures of $192K exceeded it, leaving free cash flow of −$2.4M.

Questions

What was Tenon Medical's revenue in the fourth quarter 2025?

Tenon Medical (TNON) reported revenue of $1.5M for the fourth quarter 2025 (Q4 2025), +92% from a year earlier and +26% from the quarter before.

Was Tenon Medical profitable in the fourth quarter 2025?

Operating loss was $2.9M (-193.5% of revenue) and net loss $2.8M.

Open the interactive Sankey →

Source: Tenon Medical 10-K on SEC EDGAR.